Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 6 40-6, 1999, Pages

  Mohamed Ali, Vidya ^a   Goodrick, Steven ^a   Bulmer, Karen ^a   Holly, Jeffrey M P ^b   Yudkin, John S ^a   Coppack, Simon W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Interleukin 6; Obesity; Soluble receptors; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SUBCUTANEOUS TISSUE;

EID: 0033373619     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.6.e971     Document Type: Article

References (24)

1. Benveniste, E. N., L. P. Tang, and R. M. Law. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int. J. Dev. Neurosci. 13: 341-349, 1995.
2. Engelmann, H., H. Holtmann, C. Brakebusch, Y. S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265: 14497-14504, 1990.
3. Frayn, K. N., S. W. Coppack, S. M. Humphries, and P. L. Whyte. Metabolic characteristics of human adipose tissue in vivo. Clin. Sci. (Colch.) 76: 509-516, 1989.
4. Grell, M. Tumor necrosis factor (TNF) receptors in cellular signalling of soluble and membrane-expressed TNF. J. Inflamm. 47: 8-17, 1995.
5. Grunfeld, C., and K. R. Feingold. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3: 143-158, 1991.
6. Hirano, T. Interleukin-6 and its receptor: ten years later. Int. Rev. Immunol. 16: 249-284, 1998.
7. Hotamisligil, G. S., P. Arner, R. L. Atkinson, and B. M. Spiegelman. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46: 451-455, 1997.
8. Hotamisligil, G. S., P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95: 2409-2415, 1995.
9. Hotamisligil, G. S., A. Budavari, D. Murray, and B. M. Speigelman. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94: 1543-1549, 1994.
10. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, L. A. Kuramoto, and T. Kishimoto. Autocrine generation, and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988.
11. Kern, P. A., M. Saghizadeh, J. M. Ong, R. J. Bosch, R. Deem, and R. B. Simsolo. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95: 2111-2119, 1995.
12. Kishimoto, T., M. Hibi, M. Murakami, M. Narazaki, M. Saito, and T. Taga. Molecular biology of interleukin-6 and its receptor. Ciba Found. Symp. 167: 5-23, 1992.
13. Klein, S., S. W. Coppack, V. Mohamed-Ali, and M. Landt. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45: 984-987, 1996.
14. Luheshi, G., and N. Rothwell. Cytokines and fever. Int. Arch. Allergy Immunol. 109: 301-307, 1996.
15. Mohamed-Ali, V., S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82: 4196-4200, 1997.
16. Mohamed-Ali, V., J. H. Pinkney, and S. W. Coppack. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. 22: 1145-1158, 1998.
17. Montero-Julian, F. A., J. Liautard, S. Flavetta, F. Romagne, J. P. Gaillard, J. Brochier, B. Klein, and H. Brailly. Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions. J. Immunol. Methods 169: 111-121, 1994.
18. Novick, D., H. Engelmann, D. Wallach, and M. Rubinstein. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170: 1409-1414, 1989.
19. Simonsen, L., J. Bülow, and J. Madsen. Adipose tissue metabolism in humans determined by vein catherization and microdialysis techniques. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E357-E365, 1994.
20. Strassman, G., M. Fong, S. Windsor, and R. Neta. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5: 285-290, 1993.
21. Summers, L. K. M., J. S. Samra, S. M. Humphreys, and R. J. Morris. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin. Sci. (Colch.) 91: 679-683, 1996.
22. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 58: 573-581, 1989.
23. Van-Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4845-4849, 1992.
24. Yasukawa, K., K. Futatsugi, T. Saito, H. Yawata, M. Narazaki, H. Suzuki, T. Taga, and T. Kishimoto. Association of recombinant soluble IL-6-signal transducer, gp 130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp 130. Immunol. Lett. 31: 123-130, 1992.